Key result
Highest TyG index quartile linked to ~36% higher mortality in AF with metabolic syndrome.
Why the study?
Whether triglyceride-glucose-related indices are linked to all-cause and cardiovascular mortality in individuals with coexisting AF and MetS was unclear.
Do higher triglyceride-glucose-related indices increase the risk of all-cause and cardiovascular mortality in individuals with coexisting atrial fibrillation and metabolic syndrome?
Cohort (n=2,535)
Yes
Do higher triglyceride-glucose-related indices increase the risk of all-cause and cardiovascular mortality in individuals with coexisting atrial fibrillation and metabolic syndrome?
Hazard Ratio: 1.36 (95% CI 1.14–1.64)
p-value: p=<0.001
Higher triglyceride-glucose-related indices are independently associated with increased all-cause and cardiovascular mortality in patients with coexisting atrial fibrillation and metabolic syndrome.
TyG index was associated with higher mortality in AF-metabolic syndrome; leaves open whether it is modifiable or actionable.
BACKGROUND: The triglyceride-glucose (TyG) related indices are simple biomarkers of insulin resistance and are associated with metabolic syndrome (MetS) and atrial fibrillation (AF). However, whether TyG-related indices are linked to all-cause and cardiovascular mortality in individuals with coexisting AF and MetS remains unclear. METHODS: We included 2535 participants with both AF and MetS from the UK Biobank. TyG-related indices, including TyG, TyG combined with body mass index (TyG-BMI), TyG combined with waist circumference (TyG-WC), and TyG combined with the waist-to-height ratio (TyG-WHtR), were calculated. The study endpoints were all-cause and cardiovascular mortality. Participants were followed until death or December 31, 2023, whichever occurred first. Associations between TyG-related indices and mortality outcomes were assessed using Cox proportional hazards models and restricted cubic spline (RCS) analyses. RESULTS: Over a mean follow-up period of 12.7 years (IQR: 11.8‒15.2), 956 all-cause deaths and 385 cardiovascular deaths were documented. Kaplan‒Meier survival analyses revealed the highest incidence of all-cause mortality in the fourth quartile of TyG (log-rank P < 0.001). Compared with individuals in the second quartile, individuals in the highest quartile had a significantly increased risk of all-cause mortality (TyG: hazard ratio (HR) 1.36, 95% confidence interval (CI): (1.14‒1.64); TyG-BMI: 1.31, 1.10‒1.56; TyG-WC: 1.41, 1.18‒1.68; TyG-WHtR: 1.56, 1.3‒-1.86). Moreover, TyG, TyG-BMI, and TyG-WHtR were significantly associated with cardiovascular mortality (TyG: HR 1.47, 95% CI 1.10‒1.95; TyG-WC: 1.41, 1.03‒1.93; TyG‒WHtR: 1.35, 1.01‒1.80). RCS analyses revealed nonlinear association between TyG and mortality and between TyG-BMI and all-cause mortality (all P < 0.05). The results of the sensitivity and subgroup analyses were consistent with those of the primary analyses. CONCLUSIONS: This study demonstrateed the prognostic value of TyG-related indices in individuals with AF and MetS. These indices may serve as practical surrogate markers for risk stratification and the prevention of adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2025) conducted a cohort in Atrial fibrillation and metabolic syndrome (n=2,535). Highest quartile of triglyceride-glucose (TyG) index vs. Second quartile of TyG index was evaluated on All-cause mortality (HR 1.36, 95% CI 1.14-1.64, p=<0.001). Compared to the second quartile, individuals in the highest quartile of the TyG index had a significantly increased risk of all-cause mortality (HR 1.36) among patients with atrial fibrillation and metabolic syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: